Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,830,314
-$21,898,372 QoQ
Shares Held
197,372
-85.9% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Quantinno Capital Management LP holds $621,995,665 across 28 Diagnostics & Research names. SHC ranks #16 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
188,243 | $92,527,081 | |
| 2 | DHR |
Danaher Corp /De/
|
401,864 | $76,193,414 | |
| 3 | ILMN |
Illumina, Inc.
|
617,543 | $76,118,350 | |
| 4 | A |
Agilent Technologies, Inc.
|
527,679 | $60,144,852 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
99,794 | $56,073,250 | |
| 6 | DGX |
Quest Diagnostics Inc
|
231,025 | $45,276,279 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
233,974 | $39,901,925 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
227,069 | $39,169,402 |
All Filings in SHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,830,314 | 197,372 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,728,686 | 1,401,853 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,255,060 | 588,370 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $932,767 | 83,882 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $578,674 | 49,629 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $675,326 | 49,366 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $487,923 | 29,217 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $217,600 | 18,332 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||